Theravance Biopharma, Inc.·4

Nov 24, 6:16 PM ET

HAUMANN BRETT K 4

4 · Theravance Biopharma, Inc. · Filed Nov 24, 2020

Insider Transaction Report

Form 4
Period: 2020-11-20
HAUMANN BRETT K
SVP, Clinical Development
Transactions
  • Tax Payment

    Ordinary Shares

    2020-11-20$17.21/sh4,639$79,837278,171 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -